Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
33
Number of overlapping holdings
16.5%
% of IBBQ's 200 holdings also in IDNA
73.3%
% of IDNA's 49 holdings also in IBBQ
Overlap by Weight
Sector Drift (IBBQ minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 8.9% | 4.8% | 4.8% |
|
REGENERON PHARMACEUTICALS | 8.8% | 4.6% | 4.6% |
|
MODERNA, INC. | 2.9% | 2.0% | 2.0% |
|
INCYTE CORP | 1.4% | 4.4% | 1.4% |
|
SAREPTA THERAPEUTICS INC | 1.3% | 4.3% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
IBBQ Overweight Relative to IDNA
|
AMGEN INC | 7.9% |
|
VERTEX PHARMACEUTICALS INC | 7.9% |
|
REGENERON PHARMACEUTICALS | 4.1% |
|
GILEAD SCIENCES INC | 4.1% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.1% |
|
ALNYLAM PHARMACEUTICALS INC | 3.2% |
|
BIOGEN IDEC INC | 2.9% |
|
ILLUMINA INC | 2.0% |
|
BIOMARIN PHARMACEUTICAL INC | 1.7% |
 |
ARGENX SE ADR | 1.6% |
IBBQ Underweight Relative to IDNA
 |
ROCHE HOLDING LTD | -4.9% |
 |
BEIGENE, LTD. | -4.8% |
 |
SANOFI-AVENTIS | -4.4% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -4.3% |
|
GSK PLC | -4.1% |
|
EXELIXIS INC | -3.9% |
 |
GENMAB A/S | -3.9% |
|
MERCK & CO. INC. | -3.6% |
|
REVOLUTION MEDICINES, INC. | -3.5% |
|
SAREPTA THERAPEUTICS INC | -3.1% |